Join
Live feed
·
PRReleasevia Quantisnow
Genprex Inc. logo

Genprex Announces First Patient Dosed in Phase 2 Expansion Portion of Acclaim-3 Clinical Study of Reqorsa® Gene Therapy in Combination with Tecentriq® to Treat Small Cell Lung Cancer

ByQuantisnow·Wall Street's wire, on your screen.
GNPX· Genprex Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track GNPX (Genprex Inc.) and more on Quantisnow.